Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease

American Journal of Pathology

Volumn 163, Issue 2, 2003, Pages 591-607

  An, Wen Lin ^a,b   Cowburn, Richard F ^a   Li, Lin ^b   Braak, Heiko ^c   Alafuzoff, Irina ^d   Iqbal, Khalid ^e   Iqbal, Inge Grundke ^e   Winblad, Bengt ^a   Pei, Jin Jing ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c GOETHE UNIVERSITY   (Germany)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; PROTEIN; RAB PROTEIN; RAPAMYCIN; S6 KINASE; SERINE; TAU PROTEIN; THREONINE; UBIQUITIN; UNCLASSIFIED DRUG; ZINC SULFATE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOSYNTHESIS; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REGRESSION ANALYSIS; RNA TRANSLATION; TRANSLATION REGULATION;

EID: 0041343303     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63687-5     Document Type: Article

References (81)

1. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaide MS, Wisniewski HM: Microtubule-associated protein tau, a component of Alzheimer-paired helical filaments. J Biol Chem 1986, 261:6084-6089
2. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder I: Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeleton pathology. Proc Nat Acad Sci USA 1986, 83:4913-4917
3. Braak H, Braak E, Grundke-Iqbal I, Iqbal K: Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett 1986, 165:351-355
4. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B: Defective brain microtubule assembly in Alzheimer's disease. Lancet 1986, 2:421-426
5. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung Y-C, Zaidi T: Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 1989, 86:5646-5650
6. Khatoon S, Grundke-Iqbal I, Iqbal K: Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 1992, 59:750-753
7. Khatoon S, Grundke-Iqbal I, Iqbal K: Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEBS Lett 1994, 351:80-84
8. Alonso A del C, Zaidi T, Grundke-Iqbal I, Iqbal K: Role of abnormally hyperphosphorylated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 1994, 91:5562-5566
9. Alonso AC, Grundke-Iqbal I, Iqbal K: Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 1996, 2:783-787
10. Grove JR, Banerjee P, Balasubramanyam A, Coffer PJ, Price DJ, Avruch J, Woodgett JR: Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini. Mol Cell Biol 1991, 11:5541-5550
11. Reinhard C, Thomas G, Kozma SC: A single gene encodes two isoforms of the p70 S6 kinase: activation upon mitogenic stimulation. Proc Natl Acad Sci USA 1992, 89:4052-4056
12. s6k: functional requirement for entry into S phase. EMBO J 1994, 13:1557-1565
13. Dufner A, Thomas G: Ribosomal S6 kinase signaling and the control of translation. Exp Cell Res 1999, 253:100-109
14. Domin J, Waterfield MD: Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett 1997, 410:91-95
15. Jeno P, Ballou LM, Novak-Hofer I, Thomas G: Identification and characterization of a mitogenic-activated S6 Kinase. Proc Natl Acad Sci USA 1988, 85:406-410
16. Mukhopadhyay NK, Price DJ, Kyriakis JM, Pelech S, Sanghera J, Avruch J: An array of insulin-activated, proline-directed serine/threonine protein kinases phosphorylate the p70 S6 kinase. J Biol Chem 1992, 267:3325-3335
17. s6k by PDK1. Science 1998, 279:707-710
18. Stewart MJ, Thomas G: Mitogenesis and protein synthesis: a role for ribosomal protein S6 phosphorylation? BioEssays 1994, 16:1-7
19. Flotow H, Thomas G: Substrate recognition determinants of the mitogen-activated 70K S6 kinase from rat liver. J Biol Chem 1992, 267:3074-3078
20. Lane HA, Fernandez A, Lamb NJ, Thomas G: p70s6k function is essential for G1 progression. Nature 1993, 363:170-172
21. Berven LA, Crouch MF: Cellular function of p70S6K: a role in regulating cell motility. Immunol Cell Biol 2000, 78:447-451
22. Braak H, Braak E: Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259
23. Bae GU, Seo DW, Kwon HK, Lee HY, Hong S, Lee ZW, Ha KS, Lee HW, Han JW: Hydrogen peroxide activates p70 (S6k) signaling pathway. J Biol Chem 1999, 274:32596-32602
24. Kim S, Jung Y, Kim D, Koh H, Chung J: Extracellular zinc activates p70 S6 kinase through the phosphatidylinositol 3-kinase signaling pathway. J Biol Chem 2000, 275:25979-25984
25. Tu VC, Bahl JJ, Chen QM: Signals of oxidant-induced cardiomyocyte hypertrophy: key activation of p70 S6 kinase-1 and phosphoinositide 3-kinase. J Pharmacol Exp Ther 2002, 300:1101-1110
26. Lynch CJ, Patson BJ, Goodman SA, Trapolsi D, Kimball SR: Zinc stimulates the activity of the insulin- and nutrient-regulated protein kinase mTOR. Am J Physiol Endocrinol Metab 2001, 281:E25-E34
27. Deibel MA, Ehmann WD, Markesbery WR: Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J Neurol Sci 1996, 143:137-142
28. Danscher G, Jensen KB, Frederickson CJ, Kemp K, Andreasen A, Juhl S, Stoltenberg M, Ravid R: Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material. J Neurosci Methods 1997, 76:53-59
29. Cornett CR, Markesbery WR, Ehmann WD: Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 1998, 19:339-345
30. Köpke E, Tung Y-C, Shaikh S, Alonso A del C, Iqbal K, Grundke-Iqbal I: Microtubule-associated protein tau: abnormal phosphorylation of a non-paired helical pool in Alzheimer disease. J Biol Chem 1993, 268:24374-24384
31. Tatebayashi Y, Iqbal K, Grundke-Iqbal I: Dynamic regulation of expression and phosphorylation of tau by fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus. J Neurosci 1999, 9:5245-5254
32. Braak H, Braak E: Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol (Berl) 1991, 81:261-268
33. Braak H, Braak E, Ohm T, Bohl J: Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 1988, 63:197-200
34. Gallyas F: Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971, 19:1-8
35. Braak E, Braak H, Mandelkow EM: A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 1994, 87:554-567
36. Campbell SK, Switzer RC, Martin TL: Alzheimer's plaques and tangles: a controlled and enhanced silver-staining method. Soc Neurosci Abstr 1987, 13:H678
37. Braak H, Braak E, Bohl J: Staging of Alzheimer-related cortical destruction. Eur Neurol 1993, 33:403-408
38. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254
39. Iqbal K, Grundke-Iqbal I: Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease. Mol Neurobiol 1992, 5:399-410
40. Ishiguro, K, Omori A, Sato K, Tomizawa K, Imahori K, Uchida T: A serine/threonine proline kinase activity is included in the tau protein kinase fraction forming a paired helical filament epitope. Neurosci Lett 1991, 128:195-198
41. Hanger DP, Hughes K, Woodgett JR, Brion JP, Anderton BH: Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci Lett 1992, 147:58-62
42. Ledesma MD, Correas I, Avila J, Diaz-Nido J: Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett 1992, 308:218-224
43. Sengupta A, Kabat J, Novak M, Wu Q, Grundke-Iqbal I, Iqbal K: Protein phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules. Arch Biochem Biophys 1998, 357:299-309
44. Pei J-J, Braak H, Gong C-X, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF: Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration. Acta Neuropathologica 2002, 104:369-376
45. Mah VH, Eskin TA, Kazee AM, Lapham L, Higgins GA: In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer's disease. Brain Res Mol Brain Res 1992, 12:85-94
46. Yasojima K, McGeer EG, McGeer PL: Tangled areas of Alzheimer brain have upregulated levels of exon 10 containing tau mRNA. Brain Res 1999, 831:301-305
47. Chambers CB, Sigurdsson EM, Hejna MJ, Lorens SA, Lee JM, Muma NA: Amyloid-β injection in rat amygdala alters tau protein but not mRNA expression. Exp Neurol 2000, 162:158-170
48. Murakami N, Oyama F, Gu Y, McLennan IS, Nonaka I, Ihara Y: Accumulation of tau in autophagic vacuoles in chloroquine myopathy. J Neuropathol Exp Neurol 1998, 57:664-673
49. Oyama F, Murakami N, Ihara Y: Chloroquine myopathy suggests that tau is degraded in lysosomes: implication for the formation of paired helical filaments in Alzheimer's disease. Neurosci Res 1998, 31:1-8
50. Cataldo AM, Barnett JL, Pieroni C, Nixon RA: Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathological evidence for a mechanism of increased β-amyloidogenesis. J Neurosci 1997, 17:6142-6151
51. Wang GP, Khatoon S, Iqbal K, Grundke-Iqbal I: Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res 1991, 566:146-151
52. Lopez Salon M, Morelli L, Castano EM, Soto EF, Pasquini JM: Defective ubiquitination of cerebral proteins in Alzheimer's disease. J Neurosci Res 2000, 62:302-310
53. Pei J-J, Tanaka T, Tung T-C, Braak E, Iqbal K, Grundke-Iqbal I: Distribution, levels and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol 1997, 56:70-78
54. Pei J-J, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF: Distribution of active glycogen synthase kinase 3β(GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 1999, 58:1010-1019
55. Sironi JJ, Yen SH, Gondal JA, Wu Q, Grundke-Iqbal I, Iqbal K: Ser-262 in human recombinant tau protein is a markedly more favorable site for phosphorylation by CaMKII than PKA or PhK. FEBS Lett 1998, 436:471-475
56. Bennecib M, Gong C-X, Grundke-Iqbal I, Iqbal K: Inhibition of PP-2A upregulates CAMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 2001, 490:15-22
57. Nagy Z, Esiri MM, Cato AM, Smith AD: Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol (Berl) 1997, 94:6-15
58. Pei J-J, Grundke-Iqbal I, Eqbal K, Bogdanovic N, Winblad B, Cowburn RF: Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration. Brain Res 1998, 797:267-277
59. Dranovsky A, Vincent I, Gregori L, Schwarzman A, Colflesh D, Enghild J, Strittmatter W, Davies P, Goldgaber D: Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. Neurobiol Aging 2001, 22:517-528
60. Vincent I, Bu B, Hudson K, Husseman J, Nochlin D, Jin L: Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease. Neuroscience 2001, 105:639-650
61. Wang J, Tung YC, Wang Y, Li XT, Iqbal K, Grundke-Iqbal I: Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett 2001, 507:81-87
62. Vincent I, Jicha G, Rosado M, Dicksom DW: Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J. Neurosci 1997, 17:3588-3598
63. Busser J, Geldmacher DS, Herrup K: Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 1998, 18:2801-2807
64. Gomez N, Cohen P: Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 1991, 353:170-173
65. Ferreira A, Lu Q, Orecchio L, Kosik KS: Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar Aβ. Mol Cell Neurosci 1997, 9:220-234
66. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E: Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 2001, 293:1487-1491
67. Gotz J, Chen F, van Dorpe J, Nitsch RM: Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Aβ 42 fibrils. Science 2001, 293:1491-1495
68. Fratiglioni L: Epidemiology of Alzheimer's disease: issues of etiology and validity. Acta Neurol Scand 1993, 45(Suppl 1):1-70
69. Atzori C, Ghetti B, Piva R, Srinivasan AN, Zolo P, Delisle MB, Mirra SS, Migheli A: Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J Neuropathol Exp Neurol 2001, 60:1190-1197
70. Pei J-J, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF: Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. J Alzheimer Dis 2001, 3:41-48
71. Pei J-J, Braak H, An W-L, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I, Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Mol Brain Res 2002, 109:45-55
72. Gong CX, Shaikh S, Wang JZ, Zaidi T, Grundke-Iqbal I, Iqbal K: Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. J Neurochem 1995, 65:732-738
73. Gong C-X, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K: Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 2000, 275:5535-5544
74. Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K: Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain. FEBS Lett 2000, 485:87-93
75. Wang J-Z, Gong C-X, Zaidi T, Grundke-Iqbal I, Iqbal K: Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 1995, 270:4854-4860
76. Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC: A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 1995, 128:1131-1144
77. Westphal RS, Coffee RL Jr, Marotta A, Pelech SL, Wadzinski BE: Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J Biol Chem 1999, 274:687-692
78. Petritsch C, Beug H, Balmain A, Oft M: TGF-β inhibits p70 S6 kinase via protein phosphatase 2A to induce G (1) arrest. Genes Dev 2000, 14:3093-3101
79. Liu WK, Moore WT, Williams RT, Hall FL, Yen SH: Application of synthetic phospho- and unphospho-peptides to identify phosphorylation sites in a subregion of the tau molecule, which is modified in Alzheimer's disease. J Neurosci Res 1993, 34:371-376
80. Otvos L Jr., Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM: Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994, 39:669-673
81. Su JH, Cummings BJ, Cotman CW: Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 1994, 5:2358-2362